新冠疫情中心肾移植受者的COVID-19感染情况
在纽约布朗克斯区,2020年3月16日至6月2日期间132例肾移植受者SARS-CoV-2 RT-PCR阳性,5月3日至7月29日912例受者中16.6%抗体阳性。975例受者总体感染率为23.4%,RT-PCR阳性者中80%产生抗体,总死亡率20.5%,住院者死亡率37.8%。
要点
- 肾移植受者SARS-CoV-2感染率23.4%,42%的COVID-19患者通过抗体检测发现且无症状。
- RT-PCR阳性者80%在 median 44天产生SARS-CoV-2 IgG抗体。
- 住院患者死亡率37.8%,23%需肾脏替代治疗,6.3%失去移植物。
核心结论
- 肾移植受者中42%的COVID-19通过抗体检测诊断且无显著临床症状,RT-PCR阳性者80%产生抗体,住院患者死亡率高。
研究设计与样本
- 回顾性研究:2020年3月16日至6月2日132例肾移植受者SARS-CoV-2 RT-PCR阳性;5月3日至7月29日912例受者筛查SARS-CoV-2 IgG抗体。
主要发现
- 912例筛查中16.6%抗体阳性;975例(RT-PCR或IgG检测)总感染率23.4%。
- 总死亡率20.5%,住院患者死亡率37.8%;住院者23%需肾脏替代治疗,6.3%失去移植物。
- 多因素分析显示高龄、 deceased-donor 移植、前一年未接种流感疫苗、较高血清IL-6水平与死亡率相关。
关键数值与推荐
- SARS-CoV-2 IgG抗体阳性率16.6%(912例肾移植受者筛查)。
- RT-PCR或IgG检测的975例中感染率23.4%。
- RT-PCR阳性者中位44天(IQR 31-58)抗体阳性率80%。
- 总死亡率20.5%,住院患者死亡率37.8%。
- 住院患者需肾脏替代治疗23%,失去移植物6.3%。
临床怎么用
- 肾移植受者应结合抗体检测发现无症状COVID-19感染。
- 住院肾移植受者COVID-19死亡率高,需密切监测肾功能和移植物状态。
- 高龄、 deceased-donor 移植、未接种流感疫苗、高IL-6水平者死亡风险更高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We investigated the prevalence and clinical outcomes of COVID-19 in recipients of kidney transplants in the Bronx, New York, one of the epicenters of the pandemic. Between March 16 and June 2, 2020, 132 kidney transplant recipients tested positive by SARS-CoV-2 RT-PCR. From May 3 to July 29, 2020, 912 kidney transplant recipients were screened for SARS-CoV-2 IgG antibodies during routine clinic visits, of which 16.6% tested positive. Fifty-five of the 152 patients had previously tested positive by RT-PCR, while the remaining 97 did not have significant symptoms and had not been previously tested by RT-PCR. The prevalence of SARS-CoV-2 infection was 23.4% in the 975 patients tested by either RT-PCR or SARS-CoV-2 IgG. Older patients and patients with higher serum creatinine levels were more likely diagnosed by RT-PCR compared to SARS-CoV-2 IgG. Sixty-nine RT-PCR positive patients were screened for SARS-CoV-2 IgG antibodies at a median of 44 days post-diagnosis (Inter Quartile Range 31-58) and 80% were positive. Overall mortality was 20.5% but significantly higher (37.8%) in the patients who required hospitalization. Twenty-three percent of the hospitalized patients required kidney replacement therapy and 6.3% lost their allografts. In multivariable analysis, older age, receipt of deceased-donor transplantation, lack of influenza vaccination in the previous year and higher serum interleukine-6 levels were associated with mortality. Thus, 42% of patients with a kidney transplant and with COVID-19 were diagnosed on antibody testing without significant clinical symptoms; 80% of patients with positive RT-PCR developed SARS-CoV-2 IgG and mortality was high among patients requiring hospitalization.
引用
- Azzi Y, Parides M, Alani O, et al. COVID-19 infection in kidney transplant recipients at the epicenter of pandemics. Kidney Int. 2020. PMID: 33069762. doi:10.1016/j.kint.2020.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。